Related Articles
Clinical characteristics and treatment outcome of Stevens-Johnson syndrome and toxic epidermal necrolysis
Potentially life‑threatening severe cutaneous adverse reactions associated with tyrosine kinase inhibitors (Review)
Crizotinib-associated toxic epidermal necrolysis in an ALK-positive advanced NSCLC patient
Toxic epidermal necrolysis after injection of sclerosing agent and medical adhesive into oesophageal variceal ligation in a patient with a malignant liver tumour: A case report
Concomitance or consequence? Stevens‑Johnson syndrome in COVID‑19: A case report